IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates13-11-2019
13-11-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificate/issue of duplicate share certificate11-11-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In accordance with Regulation 47 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copy of the Notice published in "Financial Express" and "Desh Sewak" on 05 November 2019, regarding Board Meeting of the Company scheduled to be held on 14 November 2019. This is for your information and record please.05-11-2019
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Notice Of The Board Meeting
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the next meeting of the Board of Directors is scheduled to be held on Thursday, the 14 November 2019 inter-alia to consider and approve the financial results of the Company for the quarter and half year ended 30 September 2019. Further pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons', the Disclosure for Closure of Trading Window has already been given by the Company on 30 September 2019, with effect from 01 October 2019 till expiry of 48 hours from the date of financial results for quarter and half year ended 30 September 2019 are made public. Accordingly, the trading window shall reopen from 17 November 2019. This is for your information and record please.04-11-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the captioned subject, please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited, Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September 2019.30-10-2019
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Notification
This is to inform you that we have received a communication from US Food & Drug Administration (FDA) with respect to an inspection conducted by US Food & Drug Administration (FDA) of Ibuprofen manufacturing facilities located at Trident Complex, Mansa Road, Barnala, Punjab from 05.08.2019 to 09.08.2019. FDA has concluded that inspection is 'closed' under 21 CFR part 20.64(d)(3). This is for your information please.26-10-2019
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Certificate Under Clause 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Clause 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a certificate received from Practicing Company Secretary for the half year ended 30 September 2019.21-10-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Shareholding for the Period Ended September 30, 2019
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here16-10-2019
IOL Chemicals & Pharma makes 22.11-cr loan prepayment
IOL Chemicals & Pharmaceuticals has made a 22.11-crore prepayment of a term loan to a bank in addition to its scheduled repayments. In a notice t15-10-2019
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Half Yearly Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith compliance certificate for the half year ended 30 September 2019.15-10-2019